UK HVC 003: A Phase I Clinical Trial Exploring a Strategy to Maximise HIV Antibody Responses using Subtype C DNA, MVA and GLA Adjuvanted gp140

Joseph, Sarah and Quinn, Killian and Greenwood, Aldona and Miller, Aleisha and Cope, Alethea V. and Mckay, Paul F. and Hayes, Peter and Kopycinski, Jakub and Bouliotis, Georgious and Gilmour, Jill and McFarlane, Leon and Tatoud, Roger and Shattock, Robin J. and Lewis, David and Montefiore, David and Esteban, Mariano and Wagner, Ralf and McCormack, Sheena and Weber, Jonathan (2016) UK HVC 003: A Phase I Clinical Trial Exploring a Strategy to Maximise HIV Antibody Responses using Subtype C DNA, MVA and GLA Adjuvanted gp140. AIDS RESEARCH AND HUMAN RETROVIRUSES, 32 (Suppl1). p. 99. ISSN 0889-2229, 1931-8405

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Petra Gürster
Date Deposited: 27 Aug 2020 10:00
Last Modified: 27 Aug 2020 10:00
URI: https://pred.uni-regensburg.de/id/eprint/4163

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.